trending Market Intelligence /marketintelligence/en/news-insights/trending/BOMNOS_nI_s08Mi2cL0iJA2 content esgSubNav
In This List

Kala Pharmaceuticals president/chief business officer steps down

Blog

Gauging Supply Chain Risk In Volatile Times

Blog

Insight Weekly: Banks' efficiency push; vacuuming carbon; Big Pharma diversity goals

Blog

The Future of Risk Management Digitization in Credit Risk Management

Blog

Climate Credit Analytics: Diving into the model


Kala Pharmaceuticals president/chief business officer steps down

Kala Pharmaceuticals, Inc. said Charles McDermott stepped down as president and chief business officer on Aug. 7.

Mark Iwicki, who has been CEO and chairman of the company's board since September 2015, took over the additional role of president.

Iwicki previously served as CEO and president of biopharmaceutical company Civitas Therapeutics Inc.

McDermott's resignation was not due to any disagreement with Kala Pharmaceuticals.